A phase I study of Ag-221, a first in class, potent inhibitor of the Idh2-mutant protein, in patients with Idh2 mutant positive advanced hematologic malignancies Meeting Abstract


Authors: Agresta, S.; Stein, E. M.; Tallman, M. S.; Levine, R. L.; Yua, H.; Yen, K.; Fan, B.; Flinn, I. W.; Fathi, A. T.; Stone, R. M.; DeAngelo, D. J.; DeBotton, S.; Pollyea, D. A.
Abstract Title: A phase I study of Ag-221, a first in class, potent inhibitor of the Idh2-mutant protein, in patients with Idh2 mutant positive advanced hematologic malignancies
Meeting Title: 19th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 99
Issue: Suppl. 1
Meeting Dates: 2014 Jun 12-15
Meeting Location: Milan, Italy
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2014-06-01
Start Page: 789
Language: English
ACCESSION: WOS:000342830904043
PROVIDER: wos
PMCID: PMC4060398
Notes: Meeting Abstract: LB2434 -- 19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY -- Source: Wos